Where to Find COVID-19 Vaccines

Three easy ways to find free vaccines near you:

A Message from MIC

The Missouri Immunization Coalition would like to thank all of our coalition members and partners for your tireless efforts to protect the health of Missourians during this unprecedented time. We realize that public health and health services professionals are responding to the COVID-19 pandemic.

The Missouri Immunization Coalition remains committed to raising awareness about the importance and safety of vaccines, sharing pertinent immunization information from state and federal agencies, and protecting the citizens of Missouri from vaccine-preventable diseases. Please use this page as a resource for information on COVID-19 vaccination development, updates, and vaccination plans.

MIC COVID-19 Vaccine Toolkit

The MIC has developed a COVID-19 vaccine toolkit containing videos, cue cards, social graphics, and more. Use these assets to help spread our message.

Key Things to Know About COVID-19 Vaccines

COVID-19 vaccines are effective at helping protect against severe disease and death from the virus that causes COVID-19. Getting a COVID-19 vaccine is a safer, more reliable way to build protection than getting sick with COVID-19.

Four COVID-19 vaccines are approved or authorized in the United States to prevent COVID-19: Pfizer-BioNTech, Moderna, Novavax, and Johnson & Johnson’s Janssen (J&J/Janssen). It’s recommended that the J&J/Janssen COVID-19 vaccine only be considered in some situations.

Everyone six months of age and older may be eligible to get a COVID-19 vaccination at no cost.

Talk with your healthcare provider to learn more as COVID-19 vaccine and booster recommendations may be updated as CDC continues to monitor the latest COVID-19 data.

The FDA Authorized Bivalent Pfizer-BioNTech COVID-19 Vaccine as Booster Dose for Certain Children 6 Months through 4 Years of Age.

The U.S. Food and Drug Administration amended the emergency use authorization of the Pfizer-BioNTech COVID-19 Vaccine, Bivalent to provide for a single booster dose of the vaccine in children six months through four years of age at least two months after completion of primary vaccination with three doses of the monovalent (single strain) Pfizer-BioNTech COVID-19 Vaccine.

What Parents and Caregivers Need to Know:

  • Children 6 months through 4 years of age who completed their three-dose primary series with the monovalent Pfizer-BioNTech COVID-19 Vaccine more than two months ago are eligible to receive a single booster dose of the Pfizer- BioNTech COVID-19 Vaccine, Bivalent.
  • Since December 2022, children 6 months through 4 years of age who receive the first two doses with monovalent Pfizer-BioNTech COVID-19 Vaccine should complete their three-dose primary series with the Pfizer-BioNTech COVID-19 Vaccine, Bivalent. These children in this age group are not eligible for a booster dose of a bivalent vaccine at this time and are expected to have protection against the most serious COVID-19 outcomes. FDA’s authorization is for those children 6 months through 4 years of age who completed their 3-dose primary vaccination series with the monovalent Pfizer-BioNTech COVID-19 Vaccine before the Pfizer-BioNTech COVID-19 Vaccine, Bivalent was authorized to provide the third dose in the 3-dose primary series.
  • The Pfizer-BioNTech COVID-19 Vaccine, Bivalent includes an mRNA component corresponding to the original virus strain to provide an immune response that is broadly protective against COVID-19 and an mRNA component corresponding to the omicron variant BA.4 and BA.5 lineages to provide better protection against COVID-19 caused by the omicron variant.

It is important to stay up-to-date on COVID-19 vaccine recommendations, especially as new vaccines become available.

Bivalent COVID-19 Vaccines For Use as a Booster Dose 

U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine to authorize bivalent formulations of the vaccines for use as a single booster dose at least two months following primary or booster vaccination. The bivalent vaccines, which we will also refer to as “updated boosters,” contain two messenger RNA (mRNA) components of SARS-CoV-2 virus, one of the original strain of SARS-CoV-2 and the other one in common between the BA.4 and BA.5 lineages of the omicron variant of SARS-CoV-2.  


Make sure you are up to date with your COVID-19 vaccines before travel. Check your destination’s COVID-19 situation before traveling. Wearing a mask over your nose and mouth is recommended in indoor areas of public transportation (including airplanes) and indoors in U.S. transportation hubs (including airports).

COVID-19 Vaccine Safety and Monitoring


According to research from the National Institutes of Health, people who received low doses of the Moderna COVID-19 vaccine had strong immune memories of the virus six months after being fully vaccinated.

The findings shed light on how lasting immunity develops after vaccination.

Helpful Links

Check out the new COVID-19 vaccine toolkit for community-based organizations (CBO) from the CDC: The toolkit will help CBOs educate community members about COVID-19 vaccines, raise awareness about the benefits of vaccination, and address common questions and concerns.